uMethod Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4.56M

  • Investors
  • 3

uMethod General Information

Description

Provider of evidence-based, personalized treatment plan services intended to treat chronic diseases. The company's treatment plans propose the customization of healthcare, with medical decisions, treatments, practices, or products being tailored to a subgroup of patients, instead of a one-drug-fits-all model, enabling patients to get the customized care that they need to transform their lives.

Contact Information

Website
www.umethod.com
Formerly Known As
Muses Labs, Inc.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9660 Falls of Neuse Road
  • Suite 138-146
  • Raleigh, NC 27615
  • United States
+1 (984)
Primary Industry
Decision/Risk Analysis
Corporate Office
  • 9660 Falls of Neuse Road
  • Suite 138-146
  • Raleigh, NC 27615
  • United States
+1 (984)

uMethod Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

uMethod Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 08-Dec-2025 $4.56M Completed Generating Revenue
3. Later Stage VC (Series C) 06-Sep-2024 Completed Generating Revenue
2. Early Stage VC (Series B) 06-Jul-2017 $2.06M $2.84M Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jul-2015 $785K $785K Completed Generating Revenue
To view uMethod’s complete valuation and funding history, request access »

uMethod Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view uMethod’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

uMethod Patents

uMethod Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210327588-A1 Methods, systems, and devices for assessing the status of an individual's immune system Inactive 16-Apr-2020
US-20170053088-A1 Interactive and analytical mobile system that provides a dynamic tool for therapies to prevent and change the progression of dementia-related diseases Inactive 22-Aug-2015
US-11257593-B2 Interactive and analytical system that provides a dynamic tool for therapies to prevent and cure dementia-related diseases Active 22-Aug-2015
US-12046369-B2 Interactive and analytical system that provides a dynamic tool for therapies to prevent and cure dementia-related diseases Active 22-Aug-2015
US-12676238-B2 Interactive and analytical system that provides a dynamic tool for therapies to prevent and cure dementia-related diseases Active 22-Aug-2015 G16H50/20
To view uMethod’s complete patent history, request access »

uMethod Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

uMethod Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
NC Tweener Fund Venture Capital Minority
Quartus Capital Partners Venture Capital Minority
The Pink Ceiling Venture Capital Minority
To view uMethod’s complete investors history, request access »

uMethod FAQs

  • When was uMethod founded?

    uMethod was founded in 2013.

  • Where is uMethod headquartered?

    uMethod is headquartered in Raleigh, NC.

  • What is the size of uMethod?

    uMethod has 15 total employees.

  • What industry is uMethod in?

    uMethod’s primary industry is Decision/Risk Analysis.

  • Is uMethod a private or public company?

    uMethod is a Private company.

  • What is uMethod’s current revenue?

    The current revenue for uMethod is .

  • How much funding has uMethod raised over time?

    uMethod has raised $22.4M.

  • Who are uMethod’s investors?

    NC Tweener Fund, Quartus Capital Partners, and The Pink Ceiling have invested in uMethod.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process